Cite
Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD).
MLA
Pinto E Vairo, Filippo, et al. “Implementation of Genomic Medicine for Rare Disease in a Tertiary Healthcare System: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD).” Journal of Translational Medicine, vol. 21, no. 1, June 2023, p. 410. EBSCOhost, https://doi.org/10.1186/s12967-023-04183-7.
APA
Pinto E Vairo, F., Kemppainen, J. L., Vitek, C. R. R., Whalen, D. A., Kolbert, K. J., Sikkink, K. J., Kroc, S. A., Kruisselbrink, T., Shupe, G. F., Knudson, A. K., Burke, E. M., Loftus, E. C., Bandel, L. A., Prochnow, C. A., Mulvihill, L. A., Thomas, B., Gable, D. M., Graddy, C. B., Garzon, G. G. M., … Lazaridis, K. N. (2023). Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD). Journal of Translational Medicine, 21(1), 410. https://doi.org/10.1186/s12967-023-04183-7
Chicago
Pinto E Vairo, Filippo, Jennifer L Kemppainen, Carolyn R Rohrer Vitek, Denise A Whalen, Kayla J Kolbert, Kaitlin J Sikkink, Sarah A Kroc, et al. 2023. “Implementation of Genomic Medicine for Rare Disease in a Tertiary Healthcare System: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD).” Journal of Translational Medicine 21 (1): 410. doi:10.1186/s12967-023-04183-7.